Literature DB >> 24876933

Esophageal cancer: staging system and guidelines for staging and treatment.

Mark F Berry1.   

Abstract

Survival of esophageal cancer is improving but remains poor. Esophageal cancer stage is based on depth of tumor invasion, involvement of regional lymph nodes, and the presence or absence of metastatic disease. Appropriate work-up is critical to identify accurate pre-treatment staging so that both under-treatment and unnecessary treatment is avoided. Treatment strategy should follow guideline recommendations, and generally should be developed after multidisciplinary evaluation.

Entities:  

Keywords:  Esophageal neoplasms; esophagectomy; neoplasm staging

Year:  2014        PMID: 24876933      PMCID: PMC4037413          DOI: 10.3978/j.issn.2072-1439.2014.03.11

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  86 in total

1.  Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients.

Authors:  Jeffrey Rentz; David Bull; David Harpole; Stephen Bailey; Leigh Neumayer; Theodore Pappas; Barbara Krasnicka; William Henderson; Jennifer Daley; Shukri Khuri
Journal:  J Thorac Cardiovasc Surg       Date:  2003-05       Impact factor: 5.209

2.  Outcomes after esophagectomy: a ten-year prospective cohort.

Authors:  Stephen H Bailey; David A Bull; David H Harpole; Jeffrey J Rentz; Leigh A Neumayer; Theodore N Pappas; Jennifer Daley; William G Henderson; Barbara Krasnicka; Shukri F Khuri
Journal:  Ann Thorac Surg       Date:  2003-01       Impact factor: 4.330

3.  National trends in outcomes for esophageal resection.

Authors:  Justin B Dimick; Reid M Wainess; Gilbert R Upchurch; Mark D Iannettoni; Mark B Orringer
Journal:  Ann Thorac Surg       Date:  2005-01       Impact factor: 4.330

4.  T2N0M0 esophageal cancer.

Authors:  Thomas W Rice; David P Mason; Sudish C Murthy; Gregory Zuccaro; David J Adelstein; Lisa A Rybicki; Eugene H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  2007-01-09       Impact factor: 5.209

5.  A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia.

Authors:  Mark F Berry; B Zane Atkins; Betty C Tong; David H Harpole; Thomas A D'Amico; Mark W Onaitis
Journal:  J Thorac Cardiovasc Surg       Date:  2010-09-29       Impact factor: 5.209

6.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

7.  Effect of local therapy for the treatment of superficial esophageal cancer in non-operative candidates.

Authors:  A J Greenstein; J P Wisnivesky; V R Litle
Journal:  Dis Esophagus       Date:  2008-05-02       Impact factor: 3.429

8.  Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort.

Authors:  Grace L Smith; Benjamin D Smith; Thomas A Buchholz; Zhongxing Liao; Melenda Jeter; Stephen G Swisher; Wayne L Hofstetter; Jaffer A Ajani; Mary F McAleer; Ritsuko Komaki; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-14       Impact factor: 7.038

Review 9.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.

Authors:  F Fiorica; D Di Bona; F Schepis; A Licata; L Shahied; A Venturi; A M Falchi; A Craxì; C Cammà
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

10.  Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.

Authors:  David P Kelsen; Katryn A Winter; Leonard L Gunderson; Joanne Mortimer; Norman C Estes; Daniel G Haller; Jaffer A Ajani; Walter Kocha; Bruce D Minsky; Jack A Roth; Christopher G Willett
Journal:  J Clin Oncol       Date:  2007-08-20       Impact factor: 44.544

View more
  56 in total

1.  Prolonged postoperative length of stay is associated with poor overall survival after an esophagectomy for esophageal cancer.

Authors:  Longfei Ma; Jingpei Li; Longlong Shao; Dong Lin; Jiaqing Xiang
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

2.  Transition from open to minimally invasive en bloc esophagectomy can be achieved without compromising surgical quality.

Authors:  Anitha Kammili; Jonathan Cools-Lartigue; David Mulder; Liane S Feldman; Lorenzo E Ferri; Carmen L Mueller
Journal:  Surg Endosc       Date:  2020-06-15       Impact factor: 4.584

3.  Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer.

Authors:  Paul J Speicher; Brian R Englum; Asvin M Ganapathi; Xiaofei Wang; Matthew G Hartwig; Thomas A D'Amico; Mark F Berry
Journal:  Ann Surg       Date:  2017-04       Impact factor: 12.969

Review 4.  Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers.

Authors:  Kunitoshi Shigeyasu; Shusuke Toden; Timothy J Zumwalt; Yoshinaga Okugawa; Ajay Goel
Journal:  Clin Cancer Res       Date:  2017-01-31       Impact factor: 12.531

5.  A study about different findings of PET-CT between neoadjuvant and non-neoadjuvant therapy: SUVmax is not a reliable predictor of lymphatic involvement after neoadjuvant therapy for esophageal cancer.

Authors:  Jae Kil Park; Jae Jun Kim; Seok Whan Moon
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

6.  Thoracoscopic and laparoscopic radical esophagectomy with left neck anastomosis.

Authors:  Xue Pan; Yan Zhang; Xiangnan Li; Dengyan Zhu; Chunyang Zhang; Jia Zhao
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

7.  RKNNMDA: Ranking-based KNN for MiRNA-Disease Association prediction.

Authors:  Xing Chen; Qiao-Feng Wu; Gui-Ying Yan
Journal:  RNA Biol       Date:  2017-04-19       Impact factor: 4.652

Review 8.  Minimally invasive staging of esophageal cancer.

Authors:  Kunal Mehta; Valentino Bianco; Omar Awais; James D Luketich; Arjun Pennathur
Journal:  Ann Cardiothorac Surg       Date:  2017-03

9.  Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.

Authors:  Frank Hofheinz; Yimin Li; Ingo G Steffen; Qin Lin; Chen Lili; Wu Hua; Jörg van den Hoff; Sebastian Zschaeck
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-04-04       Impact factor: 9.236

10.  18FDG-PET/CT is useful in the follow-up of surgically treated patients with oesophageal adenocarcinoma.

Authors:  Sonia L Betancourt Cuellar; Diana P Palacio; Carol C Wu; Brett W Carter; Arlene M Correa; Wayne L Hofstetter; Edith M Marom
Journal:  Br J Radiol       Date:  2017-11-28       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.